Veytics Intelligence
2026-10-31 · NASDAQ

Is AbbVie a Buy After Its Latest Earnings Report?

Key PointsAdjusted EPS nearly doubled, but most of that comes from last year’s big research-deal charge, and underlying growth was closer to 17%.

Ler o briefing completo da Veytics

Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.